Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collaborative Transplant Study (CTS) Pre- and Post-Transplantation Covid-19 Serum Studies: Antibody Development Following a SARS-CoV-2 Infection

NCT04694573 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT04694573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04694573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collaborative Transplant Study (CTS) Pre- and Post-Transplantation Covid-19 Serum Studies: Antibody Development Following a SARS-CoV-2 Infection
Lead sponsor
Heidelberg University
Phase
Observational
Overall status
Unknown status
Start date
December 28, 2020
Completion date
December 28, 2022
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, kidney transplant failure and rejection, kidney transplant; complications, liver transplant failure and rejection, liver transplant; complications